Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Annals of the Rheumatic Diseases 71.5 (2012): S. 785-789.
- Schlagwort
-
-
Krebs
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2012
- Urheber
-
Horn, Angelika
Kireva, Trayana
Palumbo-Zerr, Katrin
Dees, Clara
Tomcik, Michal
Cordazzo, Cinzia
Zerr, Pawel
Akhmetshina, Alfiya
Ruat, Martial
Distler, Oliver
Beyer, Christian
Schett, Georg
Distler, Jörg H. W.
- URN
-
urn:nbn:de:bvb:29-opus4-78210
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Horn, Angelika
- Kireva, Trayana
- Palumbo-Zerr, Katrin
- Dees, Clara
- Tomcik, Michal
- Cordazzo, Cinzia
- Zerr, Pawel
- Akhmetshina, Alfiya
- Ruat, Martial
- Distler, Oliver
- Beyer, Christian
- Schett, Georg
- Distler, Jörg H. W.
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2012
Ähnliche Objekte (12)
Inhibition of sumoylation prevents experimental fibrosis
Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologies
Activation of pregnane X receptor inhibits experimental dermal fibrosis
Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway
Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling
Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis
Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1
Inactivation of evenness interrupted (EVI) reduces experimental fibrosis by combined inhibition of canonical and non-canonical Wnt signalling
Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis
Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis
Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis
Inhibition of sumoylation prevents experimental fibrosis
Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologies
Activation of pregnane X receptor inhibits experimental dermal fibrosis
Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway
Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling
Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis
Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1
Inactivation of evenness interrupted (EVI) reduces experimental fibrosis by combined inhibition of canonical and non-canonical Wnt signalling
Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis
Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis
Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis
Inhibition of sumoylation prevents experimental fibrosis
Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologies
Activation of pregnane X receptor inhibits experimental dermal fibrosis
Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway
Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling
Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis
Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1
Inactivation of evenness interrupted (EVI) reduces experimental fibrosis by combined inhibition of canonical and non-canonical Wnt signalling
Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis
Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis